Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.595 USD | -9.16% | -12.92% | -42.18% |
01:26pm | Guggenheim Downgrades Altimmune to Neutral From Buy | MT |
02/04 | Transcript : Altimmune, Inc. - Special Call |
Sales 2024 * | 35.71M 2.98B | Sales 2025 * | 28.57M 2.38B | Capitalization | 515M 42.93B |
---|---|---|---|---|---|
Net income 2024 * | -61M -5.09B | Net income 2025 * | -147M -12.26B | EV / Sales 2024 * | 11.8 x |
Net cash position 2024 * | 91.94M 7.67B | Net cash position 2025 * | 285M 23.75B | EV / Sales 2025 * | 8.05 x |
P/E ratio 2024 * |
-7.79
x | P/E ratio 2025 * |
-5.21
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune, Inc.
1 day | -9.16% | ||
1 week | -12.92% | ||
Current month | -36.10% | ||
1 month | -36.41% | ||
3 months | -35.78% | ||
6 months | +172.18% | ||
Current year | -42.18% |
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 30/18/30 |
Director of Finance/CFO | 66 | 31/21/31 | |
Anthony Blandin
CMP | Compliance Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 01/10/01 |
Mack Gill
BRD | Director/Board Member | 72 | 01/04/01 |
Philip Hodges
BRD | Director/Board Member | 56 | 01/03/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 6.505 | -10.40% | 2 891 409 |
26/24/26 | 7.26 | +0.83% | 2,250,760 |
25/24/25 | 7.2 | +1.69% | 2,316,111 |
24/24/24 | 7.08 | -6.47% | 2,205,337 |
23/24/23 | 7.57 | +1.34% | 3,131,602 |
Delayed Quote Nasdaq, April 29, 2024 at 11:11 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.18% | 515M | |
-2.54% | 103B | |
+1.85% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.86% | 16.05B | |
+5.53% | 13.68B | |
+34.63% | 12.17B |
- Stock Market
- Equities
- ALT Stock